skip to content

Psychiatry

 

Dr Muzaffer Kaser is an Affiliated Assistant Professor in the Department of Psychiatry at the University of Cambridge and a Consultant Psychiatrist at Cambridgeshire and Peterborough NHS Foundation Trust.

He was the lead consultant in establishing the Staff Mental Health Service (SMHS), a bespoke mental health clinic providing rapid access to assessment and treatment for NHS staff across Cambridgeshire. The service supports over 25,000 healthcare workers and delivers care through a multidisciplinary mental health team.

Dr Kaser is the Principal Investigator for the SMHS health economics evaluation study, which examines the cost-effectiveness and wider impact of this innovative care model. His experimental research focuses on the mechanisms and treatment of neurocognitive difficulties associated with psychiatric conditions. He is currently the Clinical Principal Investigator for the Cambridge site of the MRC-funded Psychosis Immune Mechanisms Stratified Study (PIMS), which investigates the role of inflammation in psychotic symptoms, apathy, and cognition in psychosis.

Dr Kaser completed his psychiatric training in Istanbul and Cambridge, specialising in general adult psychiatry and liaison psychiatry. He holds an MPhil in Translational Medicine and a PhD from the University of Cambridge, where he has also worked as an NIHR Clinical Lecturer.

He currently serves as the Mental Health Speciality Lead for the East of England within the NIHR Regional Research Delivery Network.

In addition to his clinical and research roles, Dr Kaser is a Fellow and Professional Advisor to Tutors at Emmanuel College, Cambridge, where he teaches second-year medical students. He also regularly teaches clinical medical students and welcomes supervision of Student Selected Component (SSC) projects. He is a member of the Occupational Psychiatry Special Interest Group Executive Committee and the Wellbeing Committee at the Royal College of Psychiatrists.

Publications

Key publications: 

1. Kaser M, Foley ÉM, Khandaker GM. Neurocognitive performance in depressed patients with low-grade inflammation and somatic symptoms. Brain, Behavior, & Immunity-Health. 2022 Feb 1;19:100409.
2. Kaser M, Deakin JB, Michael A, Zapata C, Bansal R, Ryan D, Cormack F, Rowe JB, Sahakian BJ. Modafinil Improves Episodic Memory and Working Memory Cognition in Patients With Remitted Depression: A Double-Blind, Randomized, Placebo-Controlled Study. Biological psychiatry. Cognitive Neuroscience and Neuroimaging. 2017 Mar 1;2(2):115-22.
3. Kaser M, Zaman R, Sahakian BJ. Cognition as a treatment target in depression. Psychological medicine. 2017 Apr;47(6):987-9.
4. Kaser M, Soltesz F, Lawrence P, Miller S, Dodds C, Croft R, Dudas RB, Zaman R, Fernandez-Egea E, Müller U, Dean A. Oscillatory underpinnings of mismatch negativity and their relationship with cognitive function in patients with schizophrenia. PloS one. 2013 Dec 17;8(12):e83255.
5. Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials. The Journal of clinical psychiatry. 2013 Nov 15;74(11):12096.

Affiliated Assistant Professor
Consultant Psychiatrist
Not available for consultancy

Affiliations